The investigational medication is a recombinant human parathyroid hormone and may be taken only by those who qualify to participate in this investigational research study. The disease leads to fragile bones and possible fractures, typically of the wrist, hip or spine.
Osteoporosis often progresses unnoticed and without pain until a debilitating fracture occurs.
If you would like to learn more about participating in this study, please send an e-mail message using the form below. Please be assured that your message has been received. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.